Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02877030
Other study ID # PedreiraE
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date April 2, 2017
Est. completion date May 5, 2018

Study information

Verified date May 2018
Source Pedreira, Érika, M.D.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Testing the effectiveness of an exercise protocol engines sensory performed through a virtual reality platform in individuals infected with HTLV-1


Description:

Crossover randomized clinical trial to be conducted with people having a previous diagnosis of HTLV-1, they can remain in standing position without assistance. They will be excluded from those presenting amputation of the lower limbs, pregnancy, psychiatric disorders, rheumatic or orthopedic diseases, other neurological disorders associated and those that are experiencing difficulty in understanding the assessment tools used. They will also be recruited to a comparative group, healthy individuals, matched for sex, age and education level. It will be performed three assessments, before randomization, after 10 weeks and after 20 weeks, which will be evaluated in balance, functional mobility, gait and posture. The participants infected with HTLV-1, will be divided into two groups by random distribution, a group will begin the treatment protocol with video game immediately after the first evaluation and the other after ten weeks, with the crossing of the groups . Concealment of allocation will be guaranteed to the examiners who will have no contact with the physiotherapist who will apply the exercise protocol and the team member responsible for drawing. Patients will also be instructed to maintain confidentiality of the entry in the exercise program to other patients and examiners.


Recruitment information / eligibility

Status Completed
Enrollment 42
Est. completion date May 5, 2018
Est. primary completion date December 20, 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- people having a previous diagnosis of HTLV-1, which can remain in standing position without assistance.

Exclusion Criteria:

- amputation of the lower limbs, pregnancy, psychiatric disorders, rheumatic or orthopedic diseases, other neurological disorders associated and those that are experiencing difficulty in understanding the assessment tools used.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Video game
The protocol sensorimotor exercises consist of a virtual game that attaches to the Nintendo Wii and using arrows that are thrown from above, players must perform weight-shifting movements in the Nintendo platform to the target be directed to the trajectory the arrows. The goal is to catch as many arrows.

Locations

Country Name City State
Brazil Universidade Católica do Salvador Salvador Bahia

Sponsors (1)

Lead Sponsor Collaborator
Pedreira, Érika, M.D.

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary Timed up and Go Functional mobility in patients with HTLV-1 undergoing rehabilitation with video game average 8 weeks
Primary Gait performance at CvMob (Software for movement analysis) Gait performance in patients with HTLV-1 undergoing rehabilitation with video game an average 8 weeks
Primary Posture analysis at CvMob (Software for movement analysis) Posture analysis in patients with HTLV-1 undergoing rehabilitation with video game average 8 weeks
Secondary Brief Pain Inventory (BPI) Pain in patients with HTLV-1 undergoing rehabilitation with video game average 8 weeks
Secondary WHOQOL BRIEF Quality of life in patients with HTLV-1 undergoing rehabilitation with video game average 8 weeks
See also
  Status Clinical Trial Phase
Completed NCT01472263 - Use of Pentoxifylline in Human T-lymphotropic Virus Type-1 (HTLV-1) Diseases Phase 3
Completed NCT01651819 - Urological Physical Therapy in HTLV-1 With Urinary Symptoms N/A
Completed NCT02439918 - Epidemic History and Iatrogenic Transmission of Blood-borne Viruses in Mid-20th Century Kinshasa N/A
Completed NCT00076843 - Hu Mik-Beta-1 to Treat HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis Phase 1